Nvidia Sees Surge in Demand Amid Supply Constraints
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 08 2026
0mins
Source: seekingalpha
- Surge in Demand: Wedbush analysts report that Nvidia's Grace Blackwell systems, including the GB300 and B300, are experiencing elevated demand, with customers indicating sourcing difficulties, suggesting demand is rising faster than expected.
- Supply Chain Advantage: While memory supply constraints remain a primary issue, Wedbush notes that Nvidia is best positioned within the tech ecosystem regarding current supply chain dynamics, outpacing competitors.
- Future Supply Commitments: Nvidia has secured DRAM and HBM supplies for 2026 and likely for 2027, with analysts suggesting that other silicon design houses face greater challenges in meeting additional demand.
- Everpure Investment Opportunity: Wedbush sees Everpure as a prime way to capitalize on sustainable NAND and DRAM price increases, forecasting enhanced sales momentum as prices rise, with an Outperform rating for both Nvidia and Everpure.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy NVDA?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on NVDA
Wall Street analysts forecast NVDA stock price to rise
41 Analyst Rating
39 Buy
1 Hold
1 Sell
Strong Buy
Current: 204.650
Low
200.00
Averages
264.97
High
352.00
Current: 204.650
Low
200.00
Averages
264.97
High
352.00
About NVDA
NVIDIA Corporation is an artificial intelligence (AI) infrastructure company. The Company is engaged in accelerated computing to help solve the challenging computational problems. Its segments include Compute & Networking and Graphics. The Compute & Networking segment includes its Data Center accelerated computing and networking platforms and AI solutions and software, and automotive platforms and autonomous and electric vehicle solutions, including software. The Graphics segment includes GeForce GPUs for gaming and personal computers (PCs), and Quadro/NVIDIA RTX GPUs for enterprise workstation graphics. Its technology stack includes the foundational NVIDIA CUDA development platform that runs on all NVIDIA GPUs, as well as hundreds of domain-specific software libraries, frameworks, algorithms, software development kits (SDKs), and application programming interfaces (APIs). Its platforms address four markets, which include Data Center, Gaming, Professional Visualization, and Automotive.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Amazon's Cloud Services Accelerate Growth Amid Market Volatility
- Cloud Revenue Growth: Amazon's first-quarter AWS revenue rose 28% year-over-year to $37.6 billion, marking its fastest growth in 15 quarters, indicating strong competitive positioning in the cloud market and expected to further boost overall company performance.
- AI-Driven Profit Enhancement: AWS's AI revenue has reached an annual run rate of $15 billion, with a backlog of $364 billion, demonstrating that investments in artificial intelligence are significantly enhancing profitability and driving overall operating margin to a record 13.1%.
- Capital Expenditure Plans: Amazon plans to invest approximately $200 billion by 2026, with $43.2 billion spent in the first quarter primarily on AWS and AI expansion, which has led to a substantial decline in free cash flow, yet management views this as a necessary investment to seize market opportunities.
- In-House Chip Design Advantage: Amazon's custom chips now run at an annual revenue rate exceeding $20 billion, up nearly 40% from the previous quarter, allowing the company to reduce reliance on external suppliers, which is expected to save tens of billions in capital expenditures while enhancing AWS's margins.
See More
AI-Driven Memory ETF Surges Amid Shortage
- ETF Performance: The Roundhill Memory ETF has surged 156% since its launch on April 2, 2026, driven by a memory shortage fueled by AI demand, making it an attractive option for investors.
- Low Investment Threshold: With a trading price around $72, a $100 investment allows for over 1.25 shares of the Roundhill Memory ETF, significantly lowering the barrier for entry into the memory market for small investors.
- Transparent Fee Structure: The ETF has an expense ratio of 0.65%, which, while higher than most index funds, remains reasonable compared to other thematic ETFs, prompting investors to weigh fees against potential returns.
- Risk Management: By focusing solely on memory companies, the Roundhill Memory ETF mitigates concentration risk associated with other semiconductor firms, making it a suitable choice for investors already holding major stocks like Nvidia, thus providing diversified investment opportunities.
See More
Hyperliquid's Recent Performance Sparks Attention
- Price Surge: Hyperliquid's price has skyrocketed by 194% in 2026, nearing an all-time high of $77; however, analysts express caution regarding its ability to sustain such high returns in the future.
- Increased Competition: With Kalshi becoming the first CFTC-regulated platform to offer perpetual futures, achieving $1 billion in trading volume in its first week, Hyperliquid faces significant pressure from emerging competitors that could impact its market share.
- Market Access Barriers: Currently, Hyperliquid cannot legally serve U.S. customers and must undergo a CFTC review to offer services, creating uncertainty that may delay its market expansion and affect profitability.
- Regulatory Environment Shift: The acceptance of perpetual futures by U.S. regulators signals the end of the
See More
Eli Lilly vs Pfizer: Dividend Yield Comparison
- Significant Sales Growth: Eli Lilly's GLP-1 weight-loss drugs Mounjaro and Zepbound saw sales increase by 125% and 80% respectively in Q1 2026, driving an overall sales gain of 56% for the company, highlighting its strong performance in the weight-loss market.
- Dividend Yield Discrepancy: Despite Eli Lilly's stock price rising over 400% in the past five years, its dividend yield stands at a mere 0.6%, significantly lower than the S&P 500's 1% and Pfizer's 6.6%, which diminishes its appeal among dividend investors.
- Pfizer's Challenges: Pfizer's stock has declined by 30% over the past five years, facing headwinds from disappointing COVID vaccine sales and several profitable drugs losing patent protection, particularly Ibrance and Eliquis, which raises concerns about its future growth prospects.
- R&D Resilience and Risks: Although Pfizer faced setbacks in GLP-1 drug development, it is actively acquiring more promising drug candidates and plans to conduct 20 major new drug studies in 2026, demonstrating its resilience in navigating industry challenges.
See More
Netflix Stock Valuation Analysis: Cheap or Overvalued?
- Stock Performance: As of June 18, Netflix shares are trading 42% below their all-time high from June 2025, yet they have surged 715% over the past decade, indicating strong long-term growth potential and market confidence.
- P/E Ratio Analysis: Currently, Netflix's price-to-earnings ratio stands at 24.9, significantly lower than historical levels and in line with the broader S&P 500 index, suggesting that investors may find a relatively attractive entry point.
- Competitive Landscape: With competitors like Alphabet's YouTube and Meta's Instagram capturing more viewer attention, Netflix faces unprecedented challenges in maintaining its growth trajectory, especially with over 325 million subscribers already on board.
- Rising Content Costs: As Netflix invests more in acquiring rights for live events and sports, content costs are expected to rise, which could pressure its profitability, prompting investors to carefully assess its future financial performance.
See More
QQQ Fund Shows Strong Performance, Optimistic AI Investment Outlook
- Significant Annual Returns: As of June 18, 2026, the QQQ fund has risen 20.56% year-to-date and 40.01% over the past year, demonstrating strong market performance that attracts increased investor interest.
- Concentration in Top Holdings: The top three holdings, NVIDIA, Microsoft, and Apple, account for 25% of the fund's total assets, indicating that investors need to manage position sizes carefully to mitigate potential concentration risks and avoid impacts from individual stock volatility.
- Improving Macro Environment: The Fed funds rate has decreased to 3.75%, down 0.75 percentage points over the past 12 months, which enhances the present value of future earnings, providing a better valuation basis for growth stocks and further driving QQQ's growth potential.
- Long-Term Investment Value: With a staggering 591.13% return over the past decade, QQQ demonstrates its potential as a crucial component of retirement portfolios, especially in the current market environment, appealing to investors seeking stable growth.
See More
Amazon's Cloud Services Accelerate Growth Amid Market Volatility
- Cloud Revenue Growth: Amazon's first-quarter AWS revenue rose 28% year-over-year to $37.6 billion, marking its fastest growth in 15 quarters, indicating strong competitive positioning in the cloud market and expected to further boost overall company performance.
- AI-Driven Profit Enhancement: AWS's AI revenue has reached an annual run rate of $15 billion, with a backlog of $364 billion, demonstrating that investments in artificial intelligence are significantly enhancing profitability and driving overall operating margin to a record 13.1%.
- Capital Expenditure Plans: Amazon plans to invest approximately $200 billion by 2026, with $43.2 billion spent in the first quarter primarily on AWS and AI expansion, which has led to a substantial decline in free cash flow, yet management views this as a necessary investment to seize market opportunities.
- In-House Chip Design Advantage: Amazon's custom chips now run at an annual revenue rate exceeding $20 billion, up nearly 40% from the previous quarter, allowing the company to reduce reliance on external suppliers, which is expected to save tens of billions in capital expenditures while enhancing AWS's margins.
See More
AI-Driven Memory ETF Surges Amid Shortage
- ETF Performance: The Roundhill Memory ETF has surged 156% since its launch on April 2, 2026, driven by a memory shortage fueled by AI demand, making it an attractive option for investors.
- Low Investment Threshold: With a trading price around $72, a $100 investment allows for over 1.25 shares of the Roundhill Memory ETF, significantly lowering the barrier for entry into the memory market for small investors.
- Transparent Fee Structure: The ETF has an expense ratio of 0.65%, which, while higher than most index funds, remains reasonable compared to other thematic ETFs, prompting investors to weigh fees against potential returns.
- Risk Management: By focusing solely on memory companies, the Roundhill Memory ETF mitigates concentration risk associated with other semiconductor firms, making it a suitable choice for investors already holding major stocks like Nvidia, thus providing diversified investment opportunities.
See More
Hyperliquid's Recent Performance Sparks Attention
- Price Surge: Hyperliquid's price has skyrocketed by 194% in 2026, nearing an all-time high of $77; however, analysts express caution regarding its ability to sustain such high returns in the future.
- Increased Competition: With Kalshi becoming the first CFTC-regulated platform to offer perpetual futures, achieving $1 billion in trading volume in its first week, Hyperliquid faces significant pressure from emerging competitors that could impact its market share.
- Market Access Barriers: Currently, Hyperliquid cannot legally serve U.S. customers and must undergo a CFTC review to offer services, creating uncertainty that may delay its market expansion and affect profitability.
- Regulatory Environment Shift: The acceptance of perpetual futures by U.S. regulators signals the end of the
See More
Eli Lilly vs Pfizer: Dividend Yield Comparison
- Significant Sales Growth: Eli Lilly's GLP-1 weight-loss drugs Mounjaro and Zepbound saw sales increase by 125% and 80% respectively in Q1 2026, driving an overall sales gain of 56% for the company, highlighting its strong performance in the weight-loss market.
- Dividend Yield Discrepancy: Despite Eli Lilly's stock price rising over 400% in the past five years, its dividend yield stands at a mere 0.6%, significantly lower than the S&P 500's 1% and Pfizer's 6.6%, which diminishes its appeal among dividend investors.
- Pfizer's Challenges: Pfizer's stock has declined by 30% over the past five years, facing headwinds from disappointing COVID vaccine sales and several profitable drugs losing patent protection, particularly Ibrance and Eliquis, which raises concerns about its future growth prospects.
- R&D Resilience and Risks: Although Pfizer faced setbacks in GLP-1 drug development, it is actively acquiring more promising drug candidates and plans to conduct 20 major new drug studies in 2026, demonstrating its resilience in navigating industry challenges.
See More
Netflix Stock Valuation Analysis: Cheap or Overvalued?
- Stock Performance: As of June 18, Netflix shares are trading 42% below their all-time high from June 2025, yet they have surged 715% over the past decade, indicating strong long-term growth potential and market confidence.
- P/E Ratio Analysis: Currently, Netflix's price-to-earnings ratio stands at 24.9, significantly lower than historical levels and in line with the broader S&P 500 index, suggesting that investors may find a relatively attractive entry point.
- Competitive Landscape: With competitors like Alphabet's YouTube and Meta's Instagram capturing more viewer attention, Netflix faces unprecedented challenges in maintaining its growth trajectory, especially with over 325 million subscribers already on board.
- Rising Content Costs: As Netflix invests more in acquiring rights for live events and sports, content costs are expected to rise, which could pressure its profitability, prompting investors to carefully assess its future financial performance.
See More
QQQ Fund Shows Strong Performance, Optimistic AI Investment Outlook
- Significant Annual Returns: As of June 18, 2026, the QQQ fund has risen 20.56% year-to-date and 40.01% over the past year, demonstrating strong market performance that attracts increased investor interest.
- Concentration in Top Holdings: The top three holdings, NVIDIA, Microsoft, and Apple, account for 25% of the fund's total assets, indicating that investors need to manage position sizes carefully to mitigate potential concentration risks and avoid impacts from individual stock volatility.
- Improving Macro Environment: The Fed funds rate has decreased to 3.75%, down 0.75 percentage points over the past 12 months, which enhances the present value of future earnings, providing a better valuation basis for growth stocks and further driving QQQ's growth potential.
- Long-Term Investment Value: With a staggering 591.13% return over the past decade, QQQ demonstrates its potential as a crucial component of retirement portfolios, especially in the current market environment, appealing to investors seeking stable growth.
See More
